Published: May, 2018

The global polymerase chain reaction (PCR) market is fairly consolidated with the dominant presence of only a handful of established companies, finds Transparency Market Research (TMR). The top five players account accounted for over 50% of the global market share in 2015. Some of the top players operating in the global PCR market include QIAGEN, Becton Dickinson, Bio-Rad Laboratories, Sigma-Aldrich Corporation, Beckman Coulter, Agilent Technologies, Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific.

TMR notes that a number of players are active in developing advanced PCR systems equipped with broadened capabilities along with an increased specificity and sensitivity, with an aim to consolidate their shares. Top players are keen on launching integrated technologies in their products that can take care of a large number molecular tests, which makes their usage cost-effective for users.

The global polymerase chain reaction market is projected to expand at a CAGR of 6.6% during the assessment period of 2014–2020 and reach a value of US$9.6 billion by the end of the forecast period. The market’s valuation in 2013 was pegged at nearly US$6.1 billion and is expected to reach a worth of US$9.6 billion by the end of 2020.

The key applications are clinical diagnostics and life sciences. Of all the segments, life sciences led and accounted for around half of the total share in the global market in 2013. This can be attributed to the extensive uptake of PCR method in various cancer therapy research in the industry.

The various regional markets for PCR are Asia Pacific, North America, Europe, and Rest of World (RoW). Of these, North America led the pack in 2013, vis-à-vis value. The regional market is anticipated to collect a revenue worth of US$3.9 bn by 2020 end. The growth is fueled by the presence of advanced diagnostic laboratories and the rising demand for novel assay systems for research in life sciences across the region.

Rising Commercial Usage in Diagnostic Laboratories by Pharmaceutical & Biotech Companies Propelling Growth

The drive for PCR methods has stemmed from the need for advanced amplification techniques in life sciences and clinical research to replicate specific or targeted strands of DNA. The potential of this revolutionary technique to underpin the development of several other advanced molecular biology techniques has stoked its popularity world over. Furthermore, the promising usage of advanced versions of PCR in the detection and quantification of gene expression is catalyzing the growth of the market.

The rising commercial usage of PCR in diagnostic laboratories of pharmaceutical and biotechnology companies in various parts of the globe is a notable factor accentuating the growth of the market. In recent years, various PCR methods have seen notable application in the accurate detection of fatal diseases such as Ebola Virus Disease and certain types of cancer.

Advent of Automated and Digital PCR create Lucrative Market Avenues

The global PCR market has benefitted immensely from the recent expansion activities of multi-chain diagnostic laboratories to tap avenues in emerging regions. In this regard, the acquiring of standalone laboratories and the rising demand for portable PCR systems is a crucial trend boosting the market.

The advent of multiplex PCR systems that promises less turnaround times, automated workflows, and advanced productivity. The growing application of real-time PCR in clinical microbiology is also an attractive development. In this context, constant advances by manufacturers for designing real time and digital PCR systems has helped in the rapid expansion of the market. The introduction of advanced systems for detecting broad range of pathogenic microbes is propelling the growth of the PCR market.

The study presented here is based on a report by Transparency Market Research (TMR) titled “Polymerase Chain Reaction (PCR) Market (Product - Instruments, and Reagents & Consumables; End-user - Pharmaceutical and Biotech Industries, Clinical Diagnostics Laboratories, Academics and Universities; Application - Clinical Diagnostics, and Life Sciences) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014–2020”.

Key Takeaways:

  • The widespread application of PCR as a cost-effective method in molecular research and clinical microbiology world over is driving the market.
  • The designing of integrated and real-time PCR systems is opening exciting prospects for players.

The global polymerase chain reaction (PCR) market is segmented based on:


  • Instruments
  • Standard PCR Systems
  • Real Time PCR Systems
  • Digital PCR Systems
  • Reagents and Consumables


  • Clinical Diagnostics
  • Life Sciences
  • Others

End User

  • Pharmaceutical and Biotechnology Industries
  • Clinical Diagnostics Labs and Hospitals
  • Academic and Research Organizations


  • North America
    • Instruments
    • Reagents and Consumables
  • Europe
    • Instruments
    • Reagents and Consumables
  • Asia Pacific
    • Instruments
    • Reagents and Consumables
  • Rest of World
    • Instruments
    • Reagents and Consumables

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”


Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453